• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

colorectal cancer

Cologuard
MedTech

Exact Sciences kicks off launch of next-gen Cologuard Plus test

Cologuard is getting an upgrade after 10 years. Exact Sciences said new genetic biomarkers in the stool DNA test have cut its rate of false positives.
Conor Hale Mar 31, 2025 6:00am
crash fall stock shares market economy down red arrow

Leap crashes as midphase data mark end of gastric cancer program

Jan 28, 2025 8:31am
blood test vials

JPM25: Guardant posts 31% sales gain as cancer blood tests grow

Jan 13, 2025 9:19am
Stock exchange concept

High dose of Cardiff's KRAS drug shows 64% ORR, sending stock up

Dec 10, 2024 4:05pm
blood test tube

Guardant awarded $292M in false advertising suit against Natera

Nov 26, 2024 10:45am
Budding Saccharomyces yeast

Engineered yeast delivers PD-1 inhibitors, shrinks mice tumors

Nov 22, 2024 3:12pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings